CSPC Pharmaceutical Group Limited (1093.HK)
HKD 6.21
(1.31%)
HKD 6.21
(1.31%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -12.45 Billion HKD | -14.14% |
| 2022 | -10.9 Billion HKD | 2.97% |
| 2021 | -11.24 Billion HKD | -35.85% |
| 2020 | -8.27 Billion HKD | -79.69% |
| 2019 | -4.6 Billion HKD | -8.19% |
| 2018 | -4.25 Billion HKD | -19.83% |
| 2017 | -3.55 Billion HKD | -89.22% |
| 2016 | -1.87 Billion HKD | -167.98% |
| 2015 | -700.51 Million HKD | -261.18% |
| 2014 | -193.95 Million HKD | -262.96% |
| 2013 | 119.01 Million HKD | -82.94% |
| 2012 | 697.49 Million HKD | -10.44% |
| 2011 | 778.8 Million HKD | 112.67% |
| 2010 | 366.21 Million HKD | 171.76% |
| 2009 | 134.75 Million HKD | -59.14% |
| 2008 | 329.82 Million HKD | 1474.16% |
| 2007 | -24 Million HKD | 93.82% |
| 2006 | -388.45 Million HKD | 21.06% |
| 2005 | -492.05 Million HKD | -174.41% |
| 2004 | 661.28 Million HKD | 1050.37% |
| 2003 | -69.58 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -8.78 Billion HKD | 0.0% |
| 2023 FY | -12.45 Billion HKD | -14.14% |
| 2023 Q4 | -12.45 Billion HKD | 0.0% |
| 2023 Q2 | -10.05 Billion CNY | 0.0% |
| 2022 Q4 | -10.9 Billion HKD | 0.0% |
| 2022 Q2 | -9.82 Billion HKD | 0.0% |
| 2022 FY | -10.9 Billion HKD | 2.97% |
| 2021 FY | -11.24 Billion HKD | -35.85% |
| 2021 Q2 | -9.53 Billion HKD | 0.0% |
| 2021 Q4 | -11.24 Billion HKD | 0.0% |
| 2020 FY | -8.27 Billion HKD | -79.69% |
| 2020 Q4 | -8.27 Billion HKD | 0.0% |
| 2020 Q2 | -6.27 Billion HKD | 0.0% |
| 2019 Q2 | -4.3 Billion HKD | 0.0% |
| 2019 FY | -4.6 Billion HKD | -8.19% |
| 2019 Q4 | -4.6 Billion HKD | 0.0% |
| 2018 Q2 | -2.92 Billion HKD | 0.0% |
| 2018 FY | -4.25 Billion HKD | -19.83% |
| 2018 Q4 | -4.25 Billion HKD | 0.0% |
| 2018 Q3 | - HKD | 100.0% |
| 2017 Q1 | - HKD | 100.0% |
| 2017 Q4 | -3.55 Billion HKD | 0.0% |
| 2017 FY | -3.55 Billion HKD | -89.22% |
| 2017 Q2 | -1.76 Billion HKD | 0.0% |
| 2016 Q1 | - HKD | 100.0% |
| 2016 FY | -1.87 Billion HKD | -167.98% |
| 2016 Q4 | -1.87 Billion HKD | 0.0% |
| 2016 Q2 | -514.18 Million HKD | 0.0% |
| 2015 Q2 | -50.53 Million HKD | 0.0% |
| 2015 FY | -700.51 Million HKD | -261.18% |
| 2015 Q4 | -700.51 Million HKD | 0.0% |
| 2015 Q1 | - HKD | 100.0% |
| 2014 Q2 | 246.28 Million HKD | 0.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2014 Q3 | - HKD | -100.0% |
| 2014 FY | -193.95 Million HKD | -262.96% |
| 2014 Q4 | -193.95 Million HKD | 0.0% |
| 2013 FY | 119.01 Million HKD | -82.94% |
| 2013 Q4 | 119.01 Million HKD | 0.0% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 Q3 | - HKD | -100.0% |
| 2013 Q2 | 553.06 Million HKD | 0.0% |
| 2012 Q3 | - HKD | -100.0% |
| 2012 Q4 | 697.49 Million HKD | 0.0% |
| 2012 FY | 697.49 Million HKD | -10.44% |
| 2012 Q2 | 795.25 Million HKD | 0.0% |
| 2012 Q1 | - HKD | -100.0% |
| 2011 Q4 | 778.8 Million HKD | 0.0% |
| 2011 Q2 | 994.03 Million HKD | 0.0% |
| 2011 FY | 778.8 Million HKD | 112.67% |
| 2010 Q4 | 366.21 Million HKD | 0.0% |
| 2010 Q2 | 249.19 Million HKD | 0.0% |
| 2010 FY | 366.21 Million HKD | 171.76% |
| 2009 Q4 | 134.75 Million HKD | 0.0% |
| 2009 FY | 134.75 Million HKD | -59.14% |
| 2008 FY | 329.82 Million HKD | 1474.16% |
| 2007 FY | -24 Million HKD | 93.82% |
| 2006 FY | -388.45 Million HKD | 21.06% |
| 2005 FY | -492.05 Million HKD | -174.41% |
| 2004 FY | 661.28 Million HKD | 1050.37% |
| 2003 FY | -69.58 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|